Kun Liang

1.6k citations
48 papers · 1.3k indexed · h-index 20
Topics
RNA Interference and Gene Delivery (11 papers)Ultrasound and Hyperthermia Applications (10 papers)Virus-based gene therapy research (8 papers)
Partner nations
ChinaSingaporeJapan

In The Last Decade

Kun Liang

43 papers receiving 1.3k citations

Peers

Kun Liang
Comparison fields: 5 of 116
  • Biomedical Engineering 581
  • Biomaterials 377
  • Molecular Biology 367
  • Automotive Engineering 186
  • Materials Chemistry 129
Replace Maobin Xie with:
Maobin Xie China
K. Balagangadharan India
Sina Sharifi United States
Hee Seok Yang South Korea
Xiping Jiang China
Xiaopei Wu China
Young‐Min Kim South Korea
Amir Zarebkohan Iran
Alireza Hassani Najafabadi United States
Kun Liang relative to Maobin Xie China Maobin Xie's profile →
Citations per field
00.5×1.5×
Maobin Xie · 1×
Citations per year

Countries citing papers authored by Kun Liang

Since Specialization
Citations

This map shows the geographic impact of Kun Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Liang more than expected).

Fields of papers citing papers by Kun Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Liang. The network helps show where Kun Liang may publish in the future.

Co-authorship network of co-authors of Kun Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Liang. A scholar is included among the top collaborators of Kun Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Liang. Kun Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 62
5 11
6 44
7 11
8 108
9 44
10 38
11 7
12 80
13 11
14 12
15 169
16 20
17 45
18 20
19 18
20 19

About Kun Liang

Kun Liang is a scholar working on Rehabilitation, Dermatology and Developmental Neuroscience, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (11 papers), Ultrasound and Hyperthermia Applications (10 papers) and Virus-based gene therapy research (8 papers). The work is most often cited by research in Biomaterials (377 citations), Pharmaceutical Science (108 citations) and Molecular Medicine (86 citations). Kun Liang has collaborated with scholars based in China, Singapore and Japan. Frequent co-authors include Motoichi Kurisawa, Jean‐Christophe Leroux, Davide Brambilla, Joo Eun Chung, Ki Hyun Bae, Shu Jun Gao, Zhiyi Chen, Nunnarpas Yongvongsoontorn, Shaoqiong Liu and Swee Hin Teoh. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Chemical Engineering Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026